Fang, Juemin
Ding, Na
Guo, Xianling
Sun, Yan
Zhang, Zhiwei
Xie, Bailu
Li, Zhong
Wang, Hui
Mao, Wei
Lin, Zhicai
Qin, Fei
Yuan, Min
Chu, Wenqi
Qin, Huanlong
Qian, Qijun
Xu, Qing
Clinical trials referenced in this document:
Documents that mention this clinical trial
αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib
https://doi.org/10.1136/jitc-2020-001162
Funding for this research was provided by:
Shanghai Cell Therapy Group Corporation (BZ1903)
Major National Science and Technology Projects, China (2018ZX10302207-003; 2019YFC1316202)